Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
CATrends: Nutriwashing
Lawsuits allege foods and beverages aren’t as healthy as you might think.
U-Haul Uses ‘Bait-and-Switch’ Advertising, According to Investigation by Watchdog Group
Herb Weisbaum, The ConsumerMan, Consumers’ Checkbook
iFLO AC Cleaner
Is this device maker blowing hot air when it comes to its clog-free claims?
Splash Refresher Sparkling Water
Products contain some surprising ingredients for a drink advertised as “like water.”
One Mom’s Goal to Buy American-made Products Can Teach Us All Something
CBS News